Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 220 participants.

Also called NCT07865221

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07865221
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07865221. Randomized; single masking; primary purpose treatment. Start 2026-10 (anticipated); primary completion 2028-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection
Condition
Paroxysmal Atrial Fibrillation
Condition
Pulsed Field Ablation
Condition
Left Atrial Function
Condition
Cardiology
Intervention (Device)
Novel Pulsed Field Ablation System
Intervention (Device)
Radiofrequency Ablation Catheter
Lead sponsor
Tianjin Medical University General Hospital (class: other)

Record details

Record id
cardio:ct-nct07865221
Content hash
4dee0b1aec23d3d998b9f5b71111de688ecaec19221c69227806a8473250bcc7